ASP Isotopes Inc. Common Stock (ASPI)
ASP Isotopes Inc. Common Stock operates in the Chemicals - Specialty industry of the Basic Materials sector, headquartered in Dallas, TX, US. The stock last traded at $2.92, down 0.85% on the session, giving a market capitalisation of $368.3M. On trailing twelve-month figures it carries a trailing P/E of -2.22, a net margin of -428.0%. Its beta of 3.60 implies it has historically moved more than the broad market.
ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.
ASP Isotopes Inc. Common Stock is most often compared with the following Basic Materials names: